K05.3
Conditions
Interventions
Group 1: Arm 1: Test group patients with HIV infection
Scaling / Root planing in 2003, till 2009 supportive periodontal therapy
post intervention control: clinical parameter of attachment, marginal
Sponsors
Universität Witten/Herdecke
Geschäftführung
Wissenschaftliche Direktion
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: -Systematic periodontla therapy in 2003 -HIV-seropositive status (only test group) -Antiretroviral therapy with immunoreconstitution (only test group) -Informed consent
Exclusion criteria
Exclusion criteria: -Additional systemic diseases associated with periodontal disease (e.g. diabetes mellitus) -Intake of drugs, that may lead to gingival hyperplasia (e.g. anticonvulsants) -No informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Target variable: Retention of teeth Parameter: tooth in situ Scheduled: 5 yrs postoperative Methode: clinical oral examination Instrument: eye, x-ray | — |
Secondary
| Measure | Time frame |
|---|---|
| Target parameter I: Microbial load Parameter: Periodontal pathogens Schedule: 5 yrs postoperative Method: DNA-Chip Instrument: ParoCheck10 Target parameter II: Attachment level Parameter: Pocket probing depth and recession Schedule: 5 yrs postoperative Method: clinical examination Instrument: WHO periodontal probe Target parameter III: Marginal inflammation Parameter: Bleeding on probing of the marginal gingiva Schedule: 5 yrs postoperative Method: Bleeding on probing Instrument: WHO periodontal probe | — |
Countries
Germany
Contacts
Public ContactA. Rainer Jordan
Universität Witten/Herdecke Fakultät für Gesundheit i. G. Department für Zahn-, Mund- und Kieferheilkunde Abteilung für Zahnärztliche Propädeutik
Outcome results
None listed